Skip to main content

Investors and shareholders

All the information you need about Fagron as an investment.

Q1 2026 Results 2025 Annual Report

Financial Results

Fagron Capital Markets Day

Read more

Calendar

Calendar

Find out about upcoming events

Read more

Investments

Investors Hub

Why Invest?

Read more

Press Release

Regulated information: Disclosure of a transparency notification from Aberdeen Group plc

See latest press release

Read more

FAGRON

Board of Directors

Learn more about our Board of Directors

Learn more

Title video block

Description video block

Fagron at a glance

Year 2025

Revenue
€952m
REBITDA
€193m
Net Result
€92m

Financial Results

Latest annual report

Read

Pathways

Patient Journey

From Prescription to Patient

Read

FAQ and Glossary

FAQ's

In this section you can find answers to frequently asked questions and key terms about Fagron and the pharmaceutical industry.

Read

KPIs

Regional Performance

Explore Key Performance Indicators, Business Metrics, and Operational Performance Insights.

Read

Product Factsheet

Therapies Across Clinical Areas

Dermatology, Pediatrics, Gynecology, and Chronic Care

Medication per therapy type

Left title

Left description

Title presentation

File title

Download

Contact

If you would like to receive more information about Fagron, please contact Investor Relations.

Contact

To receive our press releases please sign up here

Subscribe